Joel Greenblatt | Gotham Asset Management, Llc

Fund Stats for Q3 2013Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2013 Q3 included $3.08B in managed 13F securities and a top 10 holdings concentration of 7.88%. Gotham Asset Management, Llc's largest holding is SPDR S&P 500 ETF Trust with shares held of 177.32K. 10kreader has 37 13F filings available for Gotham Asset Management, Llc.Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2013 Q3 included $3.08B in managed 13F securities and a top 10 holdings concentration of 7.88%. Gotham Asset...

About Joel GreenblattKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including 'The Little Book that Beats the Market.' He is also an Adjunct Professor with Columbia Business School.Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what 'normalized earnings' will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings.source: gurufocus.comKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He i...

Go to:

Company	Ticker	Market Value	% Portfolio	Shares	Change	Chg. Shares	Quarter End Price	Current Price	Yearly High	Yearly Low	Market Cap	% Owned
SPDR S&P 500 ETF Trust	SPY	29.79M	0.97%	177.32K	-33.70%	-90.12K	$168.01	$390.12	$479.98	$362.17	358.05B	0.02%
United Therapeutics Corporation	UTHR	29.34M	0.95%	372.15K	9.03%	30.82K	$78.85	$220.64	$245.48	$158.38	10.04B	0.82%
Activision Blizzard, Inc.	ATVI	24.44M	0.79%	1.46M	19.82%	242.31K	$16.68	$76.83	$86.9	$56.4	60.10B	0.19%
Endo Health Solutions Inc		23.72M	0.77%	521.99K	18.50%	81.50K	$45.44
Warner Chilcott Plc Ireland		23.53M	0.76%	1.03M	-16.20%	-198.44K	$22.93
Pdl Biopharma Inc		23.04M	0.75%	2.89M	24.84%	575.18K	$7.97
Myriad Genetics, Inc.	MYGN	22.70M	0.74%	965.99K	74.78%	413.31K	$23.50	$21.52	$35.31	$16.02	1.74B	1.20%
Altria Group, Inc.	MO	22.55M	0.73%	656.46K	49.22%	216.53K	$34.35	$42.01	$57.05	$41	75.65B	0.04%
Coach Inc		21.84M	0.71%	400.56K	189.30%	262.10K	$54.53
Deluxe Corporation	DLX	21.82M	0.71%	523.68K	10.41%	49.39K	$41.66	$17.84	$38.71	$17.39	768.64M	1.22%
Cisco Systems, Inc.	CSCO	21.59M	0.70%	921.32K	43.22%	278.01K	$23.43	$43.29	$64.29	$40.82	177.87B	0.02%
Booz Allen Hamilton Holding Corporation	BAH	21.46M	0.70%	1.11M	16.28%	155.49K	$19.32	$92.49	$99.32	$69.68	12.24B	0.84%
Apple Inc.	AAPL	19.91M	0.65%	41.75K	5.16%	2.05K	$476.74	$152.37	$182.94	$129.04	2.50T	0.00%
Willis Towers Watson Public Limited Company	WTW	19.31M	0.63%	516.71K	137.91%	299.52K	$37.37	$206.75	$249.7	$187.89	22.74B	0.47%
Northrop Grumman Corporation	NOC	18.02M	0.59%	189.16K	3.40%	6.23K	$95.26	$485.08	$497.2	$344.89	75.05B	0.12%
CACI International Inc	CACI	17.86M	0.58%	258.36K	7.42%	17.85K	$69.11	$275.89	$313.52	$238.29	6.46B	1.10%
Lorillard Inc		17.55M	0.57%	392.02K	29.18%	88.56K	$44.78
Valueclick Inc		17.45M	0.57%	836.54K	270.73%	610.89K	$20.86
Chemed Corporation	CHE	17.41M	0.57%	243.53K	62.65%	93.80K	$71.50	$481.44	$539.87	$403	7.18B	1.63%
Raytheon Co		17.40M	0.57%	225.81K	-12.07%	-30.99K	$77.07

Holdings Breakdown

Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.